Advertisement

Excitotoxins pp 309-330 | Cite as

Adverse Reactions In Humans Thought To Be Related To Ingestion Of Elevated Levels Of Free Monosodium Glutamate (Msg) (Chinese Restaurant Syndrome And Other Reactions)

  • Liane Reif-Lehrer
Part of the Wenner-Gren Center International Symposium Series book series (WGS)

Abstract

Monosodium glutamate is widely used as a flavor enhancer. A number of adverse effects in humans have been attributed to ingestion of this substance. The most well known of these is the so-called Chinese Restaurant Syndrome. Various studies have been done to attempt to substantiate that glutamate is indeed the etiologic factor responsible for the reported symptoms. No measurable signs appear to be associated with the syndrome. Symptoms can be quite frightening but appear to be transient and rely on subjective reports of reactors. Other adverse reactions, presumably associated with ingestion of glutamate, are also discussed.

Keywords

Tomato Juice Monosodium Glutamate Chinese Restaurant Chinese Food Flavor Enhancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albert, E.N. (1979). J. Microwave Power, 14, 281–285.Google Scholar
  2. Albert, K., P. Hoch and H. Waelsch (1946). J. Nerv. Ment. Dis., 104, 263–274.Google Scholar
  3. Allen, D.H., and G.J. Baker (1981). N. Engl. J. Med., 305, 1154–1155.Google Scholar
  4. Alston, R.M. (1976). N. Engl. J. Med., 294, 225.Google Scholar
  5. Ambos, M., N.R. Leavitt, L. Marmorek and S.B. Wolschina (1968). N. Engl. J. Med., 279, 105.Google Scholar
  6. Andermann, F., M. Vanosse and L.S. Wolfe (1976). N. Engl. J. Med., 295, 174.Google Scholar
  7. Asnes, R.S. (1980). Clin. Pediatr. (Philadelphia), 19, 705–706.Google Scholar
  8. Bakay, L. (1972). In: Handbook of Neurochemistry, Laitha, A., ea. Plenum Press, New York, 417–427.Google Scholar
  9. Bazzano, G., J.A. D’Elia and R.E. Olson (1970). Science, 18, 1208–1209.CrossRefGoogle Scholar
  10. Bellhorn, R.W., D.A. Lipman, J. Confino and M.S. Burns (1981). Invest. Ophthalmol. Vis. Sci., 21, 237–247.Google Scholar
  11. Berry, H.K., R.E. Butcher, L.A. Elliot and R.L. Brunner (1974). Dev. Psychobiol., 7, 165–173.CrossRefPubMedGoogle Scholar
  12. Bodnar, R.J., G.M. Abrams, E.A. Zimmerman, D.T. Krieger, G. Nicholson and J.S. Kizer (1980). Neuroendocrinology, 30, 280–284.CrossRefPubMedGoogle Scholar
  13. Carter, L.T., and L. Levesque (1979). Neurobehav. Toxicol., 1, 247–251.PubMedGoogle Scholar
  14. Colman, A.D. (1978a). N. Engl. J. Med., 299, 902.Google Scholar
  15. Colman, A.D. (1978b). N. Engl. J. Med., 300, 503.Google Scholar
  16. Conacher, H.B., J.R. Iyengar, W.F. Miles and H.G. Botting (1979). J. Assoc. Off. Anal. Chem., 62, 604–609. Consumer Reports (1978). 615–619.Google Scholar
  17. Cooper, P. (1977). Fd. Cosmet. Toxicol., 15, 347–356.Google Scholar
  18. Creasey, W.A., and S.E. Malawista (1971). Biochem. Pharmacol. 20, 2917–2920.CrossRefPubMedGoogle Scholar
  19. Cunha-Vaz, J., F. De Abreu, A.J. Campos and G.M. Figo (1975). Br. J. Ophthalmol. 59, 649–656.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Dawson, R., Jr., J.J. Valdes and Z. Annau (1982). Neuroendocrinology, 34, 292–296. Department of Health, Education and Welfare (1974). FDA publication #74–2043. Washington, D.C.Google Scholar
  21. Dhindsa, K.S., R.G. Omran and R. Bhup (1981). Acta Anat., 109, 97–102.CrossRefPubMedGoogle Scholar
  22. Folkers, K., S. Shizukuishi, S.L. Scudder, R. Willis, K. Takemura and J.B. Longenecker (1981). Biochem. Biophys. Res. Comm., 100, 972–977.Google Scholar
  23. Gann, D. (1977). South. Med. J., 70, 879–881.Google Scholar
  24. Ghadimi, H. (1973). Am. J. Clin. Nutr., 26, 686–687.Google Scholar
  25. Ghadimi, H., C.L. Bhalla and D.M. Kirchenbaum (1970). Acta Paediatr. Scand. 59, 233–240.CrossRefPubMedGoogle Scholar
  26. Ghadimi, H., and S. Kumar (1972). Am. J. Clin. Nutr., 25, 643–646.Google Scholar
  27. Ghadimi, H., S. Kumar and F. Abaci (1971). Biochem. Med., 5, 447–456.CrossRefGoogle Scholar
  28. Ghezzi, P., M. Salmone, M. Recchia, G. Dagnino and S. Garattini (1980). Toxicol. Lett., 5, 417–421.CrossRefPubMedGoogle Scholar
  29. Goodman, L.S., E.A. Swinyard and J.E.P. Toman (1946). Arch. Neurol. Psychiat., 56, 20.Google Scholar
  30. Gore, M.E., and P.R. Salmon (1980). Lancet, 1, 251–252.CrossRefPubMedGoogle Scholar
  31. Hammerschmidt, D.E. (1980). N. Engl. J. Med., 302, 1191–1193.Google Scholar
  32. Himms-Hagen, J. (1970). Nature, 228, 97.CrossRefPubMedGoogle Scholar
  33. Himwich, H.E., K. Wolff, A.L. Hunsicker and W.A. Himwich (1955). J. Nerv. Ment. Dis., 121, 40.Google Scholar
  34. Johnston, G.A.R. (1973). Biochem. Pharm. 22:137–140.CrossRefPubMedGoogle Scholar
  35. Justesen, D.R. (1980). Proc. IEEE, 68, 60–67.CrossRefGoogle Scholar
  36. Kandall, S.R. (1968). N. Engl. J. Med., 278, 1123.Google Scholar
  37. Kenney, R.A. (1978). N. Engl. J. Med., 300, 503.Google Scholar
  38. Kenney, R.A. (1979). In: Glutamic Acid: Advances in Biochemistry and Physiology. Filer, L.J. Jr. et al, eds. Raven Press, New York, 363–373.Google Scholar
  39. Kenney, R.A., and C.S. Tidball (1972). Am. J. Clin. Nutr., 25, 140–146.Google Scholar
  40. Kerr, G.R., M. Wu-Lee, M. El-lozy, R. McGandy and F.J. Stare (1979). J. Am. Diet Assoc., 75, 29–33.Google Scholar
  41. Kirkendol, P.L., J.E. Pearson and N.W. Robie (1980). Clin. Exp. Pharmacol. Physiol., 7, 617–625.Google Scholar
  42. Komeda, K., M. Yokote and Y. Oki (1980). Experientia, 36, 232–234.CrossRefPubMedGoogle Scholar
  43. Krieger, D.T., A.S. Liotta, G. Nicholsen and J.S. Kizer (1979). Nature, 278, 562–563.CrossRefPubMedGoogle Scholar
  44. Kwok, R.H.M. (1968). N. Engl. J. Med., 278, 796.Google Scholar
  45. Levey, S., J.E. Harroun and S.J. Smyth (1949). J. Lab. Clin. Med., 34, 1238–1248.Google Scholar
  46. Lott, I.T., T. Coulombe, R.V. DiPaolo, E.P. Richardson Jr. and H.L. Levy (1978). Neurology, 28, 47–54.CrossRefPubMedGoogle Scholar
  47. McCall, A., B.S. Glaeser, W. Millington and R.J. Wurtman (1980). Neurobehav. Toxicol., 1, 279–283.Google Scholar
  48. Marrs, T.C., M. Salmone, S. Garattini, D. Burston and D.M. Mathews (1978). Toxicology, 11, 101–107.CrossRefPubMedGoogle Scholar
  49. Marshall, A.E. (1948). Monosodium Glutamate, A Symposium. Quartermaster Food and Container Institute for the Armed Forces, and Associates. Chicago, Ill. 4.Google Scholar
  50. Mayer-Gross, W., and J.W. Walker (1949). Biochem. J., 44, 92–97.CrossRefPubMedPubMedCentralGoogle Scholar
  51. Merritt, J.H., A.F. Chamness and S.J. Allen (1978). Radiat. Environ. Biophys., 15, 367–377.Google Scholar
  52. Moneysworth (Feb. 1975), 23. Morselli, P.L., and S. Gara Hini (1970). Nature, 227, 611.CrossRefGoogle Scholar
  53. Nemeroff C.B., and F.D. Crisley (1975). Environ. Physiol. Biochem., 5, 389–395.Google Scholar
  54. Neumann, H.H. (1976). Am. Heart J., 92, 266.CrossRefPubMedGoogle Scholar
  55. New York International Glutamate Technical Committee (1974). The Remarkable Story of Monosodium Glutamate, Food and Drug Administration, Washington, D.C.Google Scholar
  56. Nitch, C. (1976). Acta Neurochir. (Wien) 23:Suppl, 101.Google Scholar
  57. Olney, J.W. (1975). In: Sweetners: Issues and Uncertainties. National Academy of Science Forum, G.P.O., Washington, D.C.Google Scholar
  58. Olney, J.W. (1976). In: Transport Phenomena in the Nervous System: Physiological and Pathological Aspects (Advances in Experimental Medicine and Biology 69) Levi G. et al, eds. Plenum Press, New York, 497–506.Google Scholar
  59. Olney, J.W. (1980). Neurotoxicology, 2, 163–192.Google Scholar
  60. Pardridge, W.M., J.D. Connor and I.L. Crawford (1975). CRC Crit. Rev. Toxicol., 3, 159–199. Peter, R.E., O. Kah, C.R. Paulencu, H. Cook and A.L. Kyle (1980). Cell Tissue Res., 212, 429–442. Plaitakis, A., S. Berl, and M.D. Yahr (1982). Science, 216, 193–196.Google Scholar
  61. Rath, J. (1968). N. Engl. J. Med., 278, 1123.Google Scholar
  62. Reif-Lehrer, L. (1976a). Fed. Proc. 35, 2205–2212.PubMedGoogle Scholar
  63. Reif-Lehrer, L. (1976b). Pediatrics, 58, 771.PubMedGoogle Scholar
  64. Reif-Lehrer, L. (1977a). Yearbook of Pediatrics, 309–310.Google Scholar
  65. Reif-Lehrer, L. (1977b). Fed. Proc., 36, 1617–1623.PubMedGoogle Scholar
  66. Reif-Lehrer, L. (1977c). Testimony, Federation of American Societies for Experimental Biology, Bethesda, Md.Google Scholar
  67. Reif-Lehrer, L. (1982, in press). Chapter in: Current Topics in Eye Research. Academic Press, New York.Google Scholar
  68. Reif-Lehrer, L., and M.G. Stemmermann (1975). N. Engl. J. Med., 293, 1204–1205.Google Scholar
  69. Reinken, L. (1975). Acta Vitaminol. Enzymol. (Milano), 29, 252–Google Scholar
  70. Reynolds, W.A., V. Butler and N. Lemkey-Johnston (1976). J. Toxicol. Environ. Health, 2, 471–480.Google Scholar
  71. Rippere, V. (1981). Med. Hypotheses, 7, 819–823.CrossRefPubMedGoogle Scholar
  72. Roberts, P.J., J. Storm-Mathisen and G.A.R. Johnston, eds. (1981). Glutamate: Transmitter in the Central Nervous System. John Wiley & Sons, New York.Google Scholar
  73. Rodriguez-Sierra, J.F., R. Sridaran and C.A. Blake (1980). Neuroendocrinology, 31, 228–235.CrossRefPubMedGoogle Scholar
  74. Rosenblum, I., J.D. Bradley and F. Coulston (1971). Toxicol. Appl. Pharmacol., 18, 367–373.Google Scholar
  75. Rubini, M.E. (1971). Am. J. Clin. Nutr. 24, 169–171.Google Scholar
  76. Saphier, D.J., and R.G. Dyer (1981). J. Endocrinol., 89, 379–387.CrossRefPubMedGoogle Scholar
  77. Schaumburg, H.H. (1968). N. Engl. J. Med., 278, 1122.Google Scholar
  78. Schaumburg, H.H., and R. Byck (1968). N. Engl. J. Med., 279, 105.Google Scholar
  79. Schaumburg, H.H., R. Byck, R. Gerstl and J.H. Mashman (1969). Science, 163, 826.CrossRefPubMedGoogle Scholar
  80. Schubert, F., J.M. George and M. Bhaskar Rao (1980). Life Sciences, 26, 651–656.CrossRefPubMedGoogle Scholar
  81. Scriver, C.R., and D.T. Whelan (1969). Ann. N.Y. Acad. Sci., 166, 83–86.Google Scholar
  82. Sjöström, L.B. (1955). Monosodium Glutamate: A Second Symposium. Research and Development Associates, Food and Container Inst., Inc. 31.Google Scholar
  83. Smith, R.J. (1981). Science, 213, 986–987.CrossRefPubMedGoogle Scholar
  84. Stegink, L.D., L.J. Filer, Jr., G.L. Baker, S.M. Mueller and MY-C Wu-Ridout (1979). In: Glutamic Acid: Advances in Biochemistry and Physiology, Filer L.J., Jr. et al, eds. Raven Press, New York, 333–351.Google Scholar
  85. Stegink, L.D., L.J. Filer, Jr. and G.L. Baker (1981). Am. J. Clin. Nutr., 34, 1899–1905.Google Scholar
  86. Sworczak, K., M. Siekjerska and R. Komarnicka (1980). Pol. Tyg. Lek., 35, 991–992.Google Scholar
  87. Terry, L.C., J. Epelbaum and J.B. Martin (1981). Brain Res., 217, 129–142.CrossRefPubMedGoogle Scholar
  88. Tracor-Jitco, Inc. (1974). Scientific literature reviews on generally recognized as safe (GRAS) food ingredients — glutamates. Food and Drug Administration, Washington, D.C.Google Scholar
  89. Trauberman, L. (1960). Food Engineering.Google Scholar
  90. Tursky, T., M. Lassanova, M. Sramka and P. Nadvorink (1976). Acta Neurochir. (Wien) 23:Suppl., 111.Google Scholar
  91. Unna, D., and E.E. Howe (1945). Fed. Proc., 4, 138.Google Scholar
  92. Utsumi, M., Y. Hirose, K. Ishihara, H. Makimura and S. Baba (1980) Biomed. Res. 1, Suppl., 154–158.Google Scholar
  93. Weil-Malherbe, H. (1949). J. Ment. Sc., 95, 930–944.Google Scholar

Copyright information

© The Wenner-Gren Center 1983

Authors and Affiliations

  • Liane Reif-Lehrer
    • 1
  1. 1.Eye Research Institute of Retina Foundation and Harvard Medical SchoolBostonUSA

Personalised recommendations